4886.T | ASKA Pharmaceutical Holdings Co.,Ltd. Annual &

Annual Balance Sheets

(In JPY)

Breakdown	2024	2023	2022	2021	2020	2019
Total Assets	93.31 Billion	87.13 Billion	83.29 Billion	82.58 Billion	80.23 Billion	82.19 Billion
Total Current Assets	56.14 Billion	53.75 Billion	49.55 Billion	39.93 Billion	37.32 Billion	37.82 Billion
Cash And Short Term Investments	17.23 Billion	17.9 Billion	17.1 Billion	10.51 Billion	7.29 Billion	11.1 Billion
Cash and Cash Equivalents	16.73 Billion	14.5 Billion	12.1 Billion	10.51 Billion	7.29 Billion	11.1 Billion
Short Term Investments	500 Million	3.4 Billion	5 Billion	-	-	-
Net Receivables	15.57 Billion	15.21 Billion	14.48 Billion	13.15 Billion	13.79 Billion	11.02 Billion
Inventory	20.4 Billion	17.68 Billion	15.06 Billion	14.37 Billion	14.04 Billion	14 Billion
Other Current Assets	2.92 Billion	2.95 Billion	2.91 Billion	1.89 Billion	2.19 Billion	1.69 Billion
Total Non-Current Assets	37.16 Billion	33.37 Billion	33.73 Billion	42.65 Billion	42.91 Billion	44.36 Billion
Net PPE	11.26 Billion	10.79 Billion	10.93 Billion	12.67 Billion	13.53 Billion	13.57 Billion
Good Will And Intangible Assets	2.87 Billion	4.46 Billion	6.18 Billion	11.89 Billion	13.58 Billion	15.33 Billion
Good Will	-	-	-	-	-	-
Intangible Assets	2.87 Billion	4.46 Billion	6.18 Billion	11.89 Billion	13.58 Billion	15.33 Billion
Long-Term Investments	15.65 Billion	16.4 Billion	7.22 Billion	12.5 Billion	9.79 Billion	11.05 Billion
Tax Assets	5.26 Billion	1.71 Billion	2.37 Billion	3.51 Billion	3.67 Billion	2.57 Billion
Other Non Current Assets	2.11 Billion	-1 Million	7.02 Billion	2.06 Billion	2.32 Billion	1.83 Billion
Other Assets	-	2 Million	2 Million	-	-	-
Total Liabilities	31.38 Billion	32.6 Billion	34.4 Billion	38.07 Billion	38.66 Billion	38.73 Billion
Total Current Liabilities	23.96 Billion	17.65 Billion	16.01 Billion	16.73 Billion	17.12 Billion	18 Billion
Account Payables	7.35 Billion	2.83 Billion	3.11 Billion	6.45 Billion	6.04 Billion	7.1 Billion
Tax Payables	2.89 Billion	736 Million	-	936 Million	-	-
Short Term Debt	4.98 Billion	3.43 Billion	1.72 Billion	2.64 Billion	2.74 Billion	3.49 Billion
Deferred Revenue	177 Million	6.11 Billion	6.05 Billion	936 Million	-	-
Other Current Liabilities	11.45 Billion	5.26 Billion	5.11 Billion	6.69 Billion	8.33 Billion	7.39 Billion
Total Non Current Liabilities	7.41 Billion	14.95 Billion	18.39 Billion	21.33 Billion	21.53 Billion	20.73 Billion
Long-Term Debt	4.5 Billion	9.18 Billion	12.32 Billion	13.74 Billion	13.67 Billion	12.97 Billion
Deferred Revenue Non Current	-	-	-	-	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	341 Million	5.77 Billion	6.07 Billion	7.58 Billion	7.86 Billion	7.76 Billion
Other Liabilities	-	-	-	-	-	-
Total Equity	61.93 Billion	54.53 Billion	48.89 Billion	44.51 Billion	41.57 Billion	43.45 Billion
Stock Holders Equity	61.93 Billion	54.53 Billion	48.89 Billion	44.51 Billion	41.57 Billion	43.45 Billion
Common Stock	1.19 Billion	1.19 Billion	1.19 Billion	1.19 Billion	1.19 Billion	1.19 Billion
Retained Earnings	56.37 Billion	49.61 Billion	45.83 Billion	41.79 Billion	39.56 Billion	40.63 Billion
Accumulated other comprehensive income	5.79 Billion	5.21 Billion	3.47 Billion	2.73 Billion	2.07 Billion	2.99 Billion
Common Stock Equity	61.93 Billion	54.53 Billion	48.89 Billion	44.51 Billion	41.57 Billion	43.45 Billion
Capital Lease Obligation	-	-	-	-	-	-
Total Investments	16.15 Billion	14.38 Billion	12.22 Billion	12.5 Billion	9.79 Billion	11.05 Billion
Total Debt	9.48 Billion	12.62 Billion	14.04 Billion	16.39 Billion	16.41 Billion	16.46 Billion
Net Debt	-7.25 Billion	-1.88 Billion	1.94 Billion	5.88 Billion	9.12 Billion	5.36 Billion

Breakdown	2024 Q2	2024 Q1	2023 Q4	2023 FY	2023 Q3	2023 Q2
Total Assets	88.26 Billion	87.32 Billion	93.31 Billion	93.31 Billion	94.85 Billion	91.92 Billion
Total Current Assets	52.44 Billion	52 Billion	56.14 Billion	56.14 Billion	61.95 Billion	59.64 Billion
Cash And Short Term Investments	13.7 Billion	14.02 Billion	17.23 Billion	17.23 Billion	20.35 Billion	20.34 Billion
Cash and Cash Equivalents	12.7 Billion	12.02 Billion	16.73 Billion	16.73 Billion	17.45 Billion	17.44 Billion
Short Term Investments	1 Billion	2 Billion	500 Million	500 Million	2.9 Billion	2.9 Billion
Net Receivables	15.59 Billion	14.97 Billion	15.57 Billion	15.57 Billion	18.3 Billion	17.34 Billion
Inventory	20.72 Billion	20.5 Billion	20.4 Billion	20.4 Billion	19.71 Billion	18.58 Billion
Other Current Assets	2.42 Billion	2.49 Billion	2.92 Billion	2.92 Billion	3.58 Billion	3.36 Billion
Total Non-Current Assets	35.81 Billion	35.32 Billion	37.16 Billion	37.16 Billion	32.89 Billion	32.27 Billion
Net PPE	12.33 Billion	11.7 Billion	11.26 Billion	11.26 Billion	10.59 Billion	10.64 Billion
Good Will And Intangible Assets	3.17 Billion	3.4 Billion	2.87 Billion	2.87 Billion	3.18 Billion	3.61 Billion
Good Will	-	-	-	-	-	-
Intangible Assets	-	3.4 Billion	2.87 Billion	2.87 Billion	3.18 Billion	3.61 Billion
Long-Term Investments	16.12 Billion	20.21 Billion	15.65 Billion	15.65 Billion	12.41 Billion	11.22 Billion
Tax Assets	-	1 Million	5.26 Billion	5.26 Billion	2.9 Billion	2.9 Billion
Other Non Current Assets	4.18 Billion	-	2.11 Billion	2.11 Billion	3.8 Billion	3.89 Billion
Other Assets	-	-	-	-	2 Million	2 Million
Total Liabilities	24.07 Billion	23.99 Billion	31.38 Billion	31.38 Billion	34.46 Billion	33.3 Billion
Total Current Liabilities	18.6 Billion	19.54 Billion	23.96 Billion	23.96 Billion	21.52 Billion	20.03 Billion
Account Payables	5.76 Billion	6.9 Billion	7.35 Billion	7.35 Billion	4.72 Billion	3.9 Billion
Tax Payables	-	-	2.89 Billion	2.89 Billion	1.61 Billion	1.46 Billion
Short Term Debt	3.98 Billion	4.18 Billion	4.98 Billion	4.98 Billion	3.18 Billion	2.98 Billion
Deferred Revenue	1.89 Billion	-	177 Million	177 Million	2.18 Billion	2.61 Billion
Other Current Liabilities	6.96 Billion	8.46 Billion	11.45 Billion	11.45 Billion	11.43 Billion	10.54 Billion
Total Non Current Liabilities	5.46 Billion	4.45 Billion	7.41 Billion	7.41 Billion	12.94 Billion	13.26 Billion
Long-Term Debt	3.66 Billion	4.08 Billion	4.5 Billion	4.5 Billion	6.92 Billion	7.34 Billion
Deferred Revenue Non Current	-	-	-	-	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	1.8 Billion	365 Million	341 Million	341 Million	6.02 Billion	5.92 Billion
Other Liabilities	-	-	-	-	-	-
Total Equity	64.19 Billion	63.32 Billion	61.93 Billion	61.93 Billion	60.39 Billion	58.61 Billion
Stock Holders Equity	64.19 Billion	63.32 Billion	61.93 Billion	61.93 Billion	60.39 Billion	58.61 Billion
Common Stock	1.19 Billion	1.19 Billion	1.19 Billion	1.19 Billion	1.19 Billion	1.19 Billion
Retained Earnings	58.36 Billion	57.07 Billion	56.37 Billion	56.37 Billion	55.28 Billion	53.52 Billion
Accumulated other comprehensive income	5.98 Billion	6.49 Billion	5.79 Billion	5.79 Billion	5.34 Billion	5.33 Billion
Common Stock Equity	64.19 Billion	63.32 Billion	61.93 Billion	61.93 Billion	60.39 Billion	58.61 Billion
Capital Lease Obligation	-	-	-	-	-	-
Total Investments	17.12 Billion	22.21 Billion	16.15 Billion	16.15 Billion	15.31 Billion	14.12 Billion
Total Debt	7.64 Billion	8.26 Billion	9.48 Billion	9.48 Billion	10.1 Billion	10.32 Billion
Net Debt	-5.06 Billion	-3.75 Billion	-7.25 Billion	-7.25 Billion	-7.34 Billion	-7.12 Billion

Balance Sheet Charts

Telefónica Deutschland Holding AG

TELDF

Full Analysis

Annual Balance Sheets
The Amacore Group, Inc.

ACGI

Full Analysis

Annual Balance Sheets
Transcat, Inc.

TRNS

Full Analysis

Annual Balance Sheets
Direct Digital Holdings, Inc.

DRCT

Full Analysis

Annual Balance Sheets
PT Ultrajaya Milk Industry & Trading Company Tbk

ULTJ

Full Analysis

Annual Balance Sheets
VG Life Sciences Inc.

VGLS

Full Analysis

Annual Balance Sheets

Global Stocks Search

ASKA Pharmaceutical Holdings Co.,Ltd. (4886.T)

Annual Balance Sheets

Balance Sheet Charts

Telefónica Deutschland Holding AG

The Amacore Group, Inc.

Transcat, Inc.

Direct Digital Holdings, Inc.

PT Ultrajaya Milk Industry & Trading Company Tbk

VG Life Sciences Inc.